Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-010082-23Phase 2Terminated
Phase 2, randomised, double-blind trial in anorexia nervosa (AN) comparing Aripiprazole + protocolized treatment with Placebo + protocolized treatment (2 arms). Primary endpoints: Core anorexic symptoms, Body image distortion and 1 more. Started Feb 2009; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-010082-23.